Drug Profile
Indisulam
Alternative Names: E-7070; ER-35744Latest Information Update: 01 Jul 2013
Price :
$50
*
At a glance
- Originator Eisai Co Ltd
- Class Antineoplastics; Indoles; Small molecules; Sulfonamides
- Mechanism of Action Apoptosis stimulants; CDC2 protein kinase inhibitors; Mitosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer; Colorectal cancer; Gastric cancer; Solid tumours
Most Recent Events
- 01 Jul 2013 Discontinued - Phase-I for Solid tumours in United Kingdom (IV)
- 01 Jul 2013 Discontinued - Phase-II for Breast cancer in European Union (IV)
- 01 Jul 2013 Discontinued - Phase-II for Breast cancer in Japan (IV)